Industry Data
Peptide Market Data & Research Statistics 2026
Comprehensive market data, growth projections, and research trends for the global peptide therapeutics and synthesis industries. Updated quarterly.
1. Peptide Therapeutics Market Overview
The global peptide therapeutics market has experienced significant growth driven by advances in GLP-1 receptor agonists, multi-agonist peptides, and AI-enabled discovery platforms.
| Metric | Value | Source |
|---|---|---|
| Market Size (2025) | $140.86 billion | Grand View Research |
| Market Size (2026 est.) | $49.68 billion | Mordor Intelligence |
| Projected Size (2031) | $70.20 billion | Mordor Intelligence |
| Projected Size (2033) | $294.58 billion | Grand View Research |
| CAGR (2026-2031) | 7.16% | Mordor Intelligence |
| CAGR (2026-2033) | 8.73% | Grand View Research |
Note: Market size estimates vary between research firms due to differing methodologies and scope definitions. Mordor Intelligence focuses on traditional peptide therapeutics while Grand View Research includes broader biologic peptide categories including GLP-1 agonists.
2. Peptide Synthesis Market
| Metric | Value |
|---|---|
| Market Size (2025) | $0.95 billion |
| Market Size (2026 est.) | $1.01 billion |
| Projected Size (2031) | $1.37 billion |
| CAGR (2026-2031) | 6.27% |
| Solid-Phase Synthesis Share (2025) | 45.13% |
| Recombinant Expression CAGR | 13.7% |
3. GLP-1 Receptor Agonist Market
GLP-1 receptor agonists (semaglutide, tirzepatide, and related compounds) have become the primary growth driver for the peptide therapeutics market, particularly in metabolic disease applications.
| Compound | Mechanism | Primary Indication | Status |
|---|---|---|---|
| Semaglutide | GLP-1 agonist | T2D, Obesity | Approved |
| Tirzepatide | GIP/GLP-1 dual agonist | T2D, Obesity | Approved |
| Survodutide | Glucagon/GLP-1 dual agonist | MASH, Obesity | Phase III |
| Retatrutide | GIP/GLP-1/Glucagon triple agonist | Obesity | Phase III |
| Orforglipron | Oral GLP-1 agonist | T2D, Obesity | Phase III |
4. Peptide Clinical Pipeline by Therapeutic Area
| Therapeutic Area | Est. Pipeline Compounds | Growth CAGR | Key Trend |
|---|---|---|---|
| Metabolic / Obesity | 80+ | 12.3% | Multi-agonist peptides |
| Gastrointestinal | 45+ | 11.85% | GLP-2 analogs (apraglutide, glepaglutide) |
| Oncology | 120+ | 9.8% | Peptide-drug conjugates (PDCs) |
| Antimicrobial / Infectious | 60+ | 8.5% | AI-designed antimicrobial peptides |
| Neurological | 35+ | 7.2% | Neuroprotective peptides (Selank, Semax) |
| Wound Healing / Tissue Repair | 25+ | 6.9% | BPC-157, TB-500 research |
5. Research Peptide Purity Benchmarks
Purity is the primary quality indicator for research peptides. Below are the industry standard purity grades and their typical applications.
| Purity Grade | HPLC Purity | Typical Use | Testing Method |
|---|---|---|---|
| Research Grade | >95% | Screening assays | RP-HPLC |
| High Purity | >98% | In vitro studies | RP-HPLC + MS |
| Institutional Grade | >99% | Published research, reference standards | RP-HPLC + ESI-MS + amino acid analysis |
| GMP Grade | >99.5% | Clinical trials | Full pharmacopeial suite |
SHR3D Aminos provides Institutional Grade research peptides at 99%+ purity, verified by independent HPLC and mass spectrometry analysis. Every product includes a Certificate of Analysis.
6. Regional Market Share
| Region | 2025 Revenue Share | Projected CAGR (2026-2031) | Key Driver |
|---|---|---|---|
| North America | 38.34% | 7.5% | FDA approvals, research funding |
| Europe | 28.1% | 6.8% | EMA regulatory support, academic research |
| Asia-Pacific | 22.5% | 12.81% | CDMO expansion, biosimilar development |
| Latin America / RoW | 11.06% | 8.2% | Growing research infrastructure |
7. Research Peptide Search Trends
Consumer and researcher interest in peptides has grown dramatically, driven by social media awareness and high-profile FDA actions.
| Search Term | Trend (2024-2026) | Primary Audience |
|---|---|---|
| "buy research peptides" | +180% YoY | Researchers, biohackers |
| "BPC-157" | +210% YoY | Fitness, recovery research |
| "semaglutide peptide" | +340% YoY | Metabolic research |
| "peptide purity testing" | +95% YoY | Quality-conscious buyers |
| "peptide COA" | +120% YoY | Lab researchers |
| "tirzepatide research" | +280% YoY | Academic, pharma |
8. Sources & Methodology
Market data compiled from publicly available industry reports, regulatory filings, and academic databases. Search trend data derived from Google Trends and Semrush keyword analytics.
- Mordor Intelligence. "Peptide Therapeutics Market Size & Share 2026-2031."
- Grand View Research. "Peptide Therapeutics Market Size, Industry Report 2033."
- Mordor Intelligence. "Peptide Synthesis Market Size, Forecast 2031."
- Research Nester. "Peptide Synthesis Market Size, Growth Trends 2035."
- Precedence Research. "Peptide Synthesis Market Size 2026-2035."
- The Business Research Company. "Peptide Therapeutics Global Market Report 2026."
- The Peptide Effect. "State of Peptides 2026: Search Trends, Research & Market Analysis."